MedTrace Logo

Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation

NCT00822536 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1798

Last updated 2014-10-17

No results posted yet for this study

Summary

To compare treatment with aspirin alone versus the combined antiplatelet treatment aspirin and clopidogrel after 12 months of combined antiplatelet treatment following drug-eluting stent (DES) implantation.

Conditions

Interventions

DRUG

Aspirin and Clopidogrel

Aspirin \<= 325 mg/j Clopidogrel = 75 mg /j

DRUG

Aspirin

Aspirin : \<= 325 mg/j

Sponsors & Collaborators

  • Fédération Française de Cardiologie

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Gérard HELFT, MD,PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00822536 on ClinicalTrials.gov